Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash	$ 7,226,212	$ 10,177,099
Accounts receivable, net	328,782	91,277
Deferred contract costs	160,718	157,300
Other current assets, net	485,598	476,004
Contract assets	49,713
Total current assets	8,251,023	10,901,680
Intangible Assets, net	283,593	327,001
Goodwill	4,183,232	4,183,232
Total assets	12,717,848	15,411,913
Current Liabilities:
Accounts payable and accrued expenses	906,244	1,408,965
Deferred revenue	307,647	131,628
Commission liability	83,200	124,150
Convertible debt, net	228,539
Total current liabilities	1,525,630	1,664,743
Non-current Liabilities:
Convertible debt, net		224,424
Accrued severance liability	325,000	325,000
Total liabilities	1,850,630	2,214,167
Commitments and Contingencies (Note 10)
Stockholders’ Equity:
Common stock, $0.0001 par value, 250,000,000 shares authorized; 9,450,220 shares issued and outstanding as of March 31, 2024 and December 31, 2023	945	945
Additional paid in capital	173,437,683	172,714,712
Accumulated deficit	(162,588,112)	(159,530,535)
Accumulated comprehensive income	16,702	12,624
Total stockholders’ equity	10,867,218	13,197,746
Total liabilities and stockholders’ equity	$ 12,717,848	$ 15,411,913